Literature DB >> 2018421

[QT prolongation and circulatory arrest after an injection of erythromycin in a newborn infant].

A Benoit1, C Bodiou, E Villain, F Bavoux, A Checoury, J Badoual.   

Abstract

A 8 day-old full-term newborn showed severe cardiac disturbances after intravenous injection of erythromycin. The neonate, suspected of having Chlamydia pneumonitis because of tachypnea and rhinitis, had been given 5 injections of erythromycin without clinical effect. Pallor, vomiting and bradycardia developed a few minutes after the 6th injection, and ECG showed ventricular arrhythmia, prolonged QT interval and an atrioventricular block. The infant died in intensive care unit. This case and the analysis of other published cases of cardiac disturbances following the parenteral use of erythromycin, indicate the potential arrhythmogenic risk of this drug. It is suggested that newborns treated with erythromycin should be monitored by ECG.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018421

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  7 in total

Review 1.  Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.

Authors:  N Principi; S Esposito
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 2.  Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.

Authors:  Sriparna Basu; Susan Smith
Journal:  Eur J Pediatr       Date:  2020-10-12       Impact factor: 3.183

Review 3.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 4.  Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Authors:  W E Haefeli; R A Schoenenberger; P Weiss; R Ritz
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 5.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 6.  Macrolide antibiotics and the risk of cardiac arrhythmias.

Authors:  Richard K Albert; Joseph L Schuller
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

7.  Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.

Authors:  Jessica E Ericson; Christopher Arnold; Jomani Cheeseman; Jordan Cho; Sarah Kaneko; Ele'na Wilson; Reese H Clark; Daniel K Benjamin; Vivian Chu; P Brian Smith; Christoph P Hornik
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-09       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.